Although many of the frequently employed pluripotency biomarkers are glycoconjugates, a glycoconjugate-based exploration of novel cellular biomarkers has proven difficult due to technical difficulties. This study reports a new approach for the systematic overview of all major classes of oligosaccharides in the cellular glycome. The proposed method enabled mass spectrometry-based structurally intensive analyses, both qualitatively and quantitatively, of cellular N-and O-linked glycans derived from glycoproteins, glycosaminoglycans and glycosphingolipids, as well as free oligosaccharides of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) and various human cells derived from normal and carcinoma cells. Cellular total glycomes were found to be highly cell-specific, demonstrating their utility as unique cellular descriptors. Structures of glycans of all classes specifically observed in hESCs and hiPSCs tended to be immature in general, suggesting the presence of stem cell-specific glycosylation spectra. The current analysis revealed the high similarity of the total cellular glycome between hESCs and hiPSCs, although it was suggested that hESCs are more homogeneous than hiPSCs from a glycomic standpoint. Notably, this study enabled a priori identification of known pluripotency biomarkers such as SSEA-3, 4, 5 and Tra-1-60/81 were identified, as well as a panel of glycans specifically expressed by hESCs and hiPSCs.
. Extensive research has been conducted with these cells to develop disease models, methods for drug screening and, ultimately, regenerative therapies.
Because stem cells are currently defined by a combination of physical, phenotypic and functional properties, the identification of novel cell surface markers is highly advantageous for the rapid characterization and isolation of different stem cell populations.
Many of the frequently employed pluripotency biomarkers, including stage-specific embryonic antigens (SSEA-3/4/5) and tumor-rejection antigens (Tra-1-60 and Tra-1-81), are glycoconjugates (3, 4) .
These glycomarkers have been identified following the rather fortuitous development of specific antiglycoconjugate antibodies. A glycoconjugate-based approach would therefore be expected to streamline the discovery process for novel cellular biomarkers. However, such an approach has proven difficult due to technical difficulties associated with the analysis of various types of cellular glycomes, given the entire repertoire of glycoconjugate-associated sugars in cells and tissues. Glycoconjugates represent the most structurally and functionally diverse class of molecules in nature, ranging from relatively simple nuclear or cytosolic glycoproteins with dynamic monosaccharide modifications (O-GlcNAcylation) to extraordinarily complex N-and O-linked glycans (e.g., glycans derived from glycoproteins, glycosaminoglycans (GAGs) and glycosphingolipids (GSLs)) (reviewed in refs 5 and 6). Considering that cell surfaces are coated with a variety of intricately arranged glycoconjugates, and some carbohydrate epitopes (e.g, Lewis , also known as SSEA-1) may be constituents of different glycoconjugates (5), a systematic overview of all major classes of oligosaccharides within the cellular glycome would be most opportune for the identification of novel stem cell biomarkers.
To date, total cellular glycosylation analyses are scarce. Wearne et al. employed fluorescently-labeled lectins to classify structural glycosylation motifs on the stem cell surface (7), and the utility of lectin arrays for cell characterization has recently been illustrated (8, 9) . However, only a limited number of lectins and glycan-specific antibodies are in fact available, and it is often difficult to discriminate between different glycoconjugate species by these methods. Furthermore, while analysis of the total cellular glycome has been addressed in pioneering mass spectrometric work (10, 11) , no attempts have yet been made to determine all major classes of glycans within a cell or the relative concentration of each type of glycan present.
This study now provides an integrated analytical technique to visualize the entire complement of sugars in the cellular glycome, including N-glycans, O-glycans, glycosaminoglycans, GSL-associated glycans and free oligosaccharides (FOSs). The usefulness of this approach was validated by clarifying intra-and inter-glycomic correlations (correlations within and between each individual glycome of various glycoconjugates) under conditions of a perturbed glycan synthetic pathway. This approach was finally applied to delineate the glycomic profiles of hESCs and hiPSCs, as well as various human cells derived from normal and carcinoma cells. For the first time, the cellular glycomic profiles were revealed in their entirety, allowing the accurate identification of known pluripotency biomarkers and the discovery of novel pluripotency biomarker candidates.
RESULTS
Systematic survey of cellular glycomes. The general analytical scheme that was employed in this study is shown in Fig. S1 . Glycans can be regarded as a class of organic compounds that have a hemiacetal group at the reducing terminal following their enzymatic release from proteins and lipids. GSL glycans were released by digestion with EGCases I and II (12) , and N-glycans were released by digestion with PNGase F. GAGs are highly complicated molecules, and therefore, their constituent repeating disaccharides were analyzed. These repeating disaccharides can be generated upon enzymatic depolymerization with chondroitinase, heparitinase, hyaluronidase, etc. To maximize the deglycosylation/depolymerization efficiency, conditions for sample preparation, including extraction of glycoconjugates and enzymatic liberation of glycans, were optimized (Fig. S2 ).
Hemiacetal is a masked aldehyde, and because aldehydes are rare functionalities in cells, GSL/Nglycans and GAGs disaccharides can be selectively enriched by chemoselective ligation upon reaction of the aldehyde with reagents bearing hydrazide functional groups as we previously described (13) . Any impurities can then be thoroughly washed away, followed by subjection of the reagent-bound glycans to on-bead methyl esterification to render sialylated oligosaccharides that are the chemical equivalent of neutral oligosaccharides (14) . The reagent-bound glycans are finally recovered by an imine exchange reaction, which not only releases the glycans, but also allows for their recovery as derivatives of aoWR, a highly sensitive tag for MALDI-TOF (15), or 2-AB for chromatographic analysis (16) (Fig. S1a) . Apart from the technical issues, analysis of FOSs may help to characterize/describe cells. FOSs reportedly increase under conditions of endoplasmic reticulum (ER) stress (18) , which is in turn linked to various disease states (19) . As shown in previous observations that oligosaccharides with masses greater than ~1,000Da exhibited similar signal strengths, irrespective of structure (13, 20) , and that methyl esterification of sialic acid renders sialylated oligosaccharides chemically equivalent to neutral oligosaccharides, and allows simultaneous analysis of neutral and sialylated oligosaccharides (14, 21) . Some of the GSL-glycans, FOSs and O-glycans analyzed in this study have molecular masses less than 1,000 Da, and therefore the quantitative values obtained for these glycans may be underestimated, which is an issue to be addressed in the future.
Absolute quantitation allowed for determination of the relative concentration of each glycan type.
The usefulness of total glycomic analysis for the characterization/description of cells was validated using the wild-type CHO cell line and its lectin-resistant mutants (Lec1 and Lec8) (SI Results).
Perturbed glycan synthetic pathways such as those observed in the mutant CHO cells can cause unexpected glycan expression profiles, which may be difficult to predict in the absence of glycomics.
Elucidation of the total glycomes of hESC, hiPSC and other human cell lines. The methodology described above was applied to delineate the entire glycomes of four hESC lines (ES1, 3, 4 and 5 (22) (Table S2 ). The total glycomic profile of each cell line is illustrated based on the absolute amount of each type of glycan and each glycan substructure, as shown in Fig. 3 . Pie charts at the vertices of the pentagon correspond to the glycan expression profiles of N-glycans, FOSs, GAGs, GSL glycans and O-glycans. The size of each circle and its constituent colors reflect the absolute glycan quantity (pmol/100 µg protein) and the glycan substructures, respectively. As such, the relative abundance of each class of glycoconjugate and its diversity is obvious at a glance by the pentagonal cellular glycomic notations. This analysis clearly demonstrated that these glycans were highly cell type-specific in terms of both the expression amount and the composition. As shown in Fig. S6 and Fig. S7 , the four ES cells gave quite similar total glycomic patterns, with a high degree of correlation (r (correlation coefficient) = 0.933-0.994, mean = 0.963). The pentagonal glycomic profiles of the hiPSCs also gave similar patterns but with a lower degree of correlation (r = 0.804-0.989, mean = 0.921). From a glycomic point of view, these results suggest that hESCs are more homogeneous than hiPSCs. Regarding the comparison of the total glycomic profiles between hESCs and hiPSCs, a fairly high degree of correlation was observed (r = 0.743-0.970, mean = 0.896). Total glycomic profiles of some of the hiPSCs were quite similar to those of the hESCs (e.g., ES1 vs. iPS1A, r = 0.97). It is worth noting that ES5, iPS2A and iPS12A tended to be contaminated with differentiating cells, which may explain the relatively low correlation coefficient values observed for these cell lines compared with the other cell lines (Fig. S7 ). The compositions of the glycans making up each class of glycome often differed markedly depending on the cell type. In the case of N-glycans, high-mannose type glycans were commonly the major components for all cells analyzed (shown in shades of green in the pie charts for the N-glycans, Fig. 3) except for MRC-5, a normal human cell line. In contrast, the levels of pauci-mannose glycans were significantly lower in hESCs and hiPSCs (shown in shades of gray in the pie charts for the N-glycans, (27) . Note that SSEA-5 was originally identified by the fortuitous development of its specific antibody, while our approach does not rely on antibodies.
Regarding GAG disaccharides, the relative amounts of chondroitin sulfate/dermatan sulfate (CS/DS) and heparan sulfate (HS) disaccharides were comparable in hESCs and hiPSCs, while their levels varied substantially in the other cells. The vast majority of the HS disaccharides were not sulfated in hESCs and hiPSCs, while the predominant CS species was the 4-monosulfated disaccharide. O-glycans profiles of hESCs and hiPSCs were characteristic in their abundance of extended core 1 or core 2 O-glycans terminated with β1-3 galactose structures.
Identification of pluripotency biomarker candidates. In order to identify pluripotency biomarker candidates, the expression profiles were statistically compared between stem cells (hESCs and hiPSCs) and non-stem cells, and, various unique features were observed that appeared to be characteristic of the former ( Fig. S11 and S12 ). Care must be paid about the contamination of glycans originating from mouse embryonic fibroblasts (MEFs), feeder cells used for the culture of hESCs and hiPSCs. As shown in Fig. S11 , expression of a number of glycans were found to be characteristic of stem cells. This was especially true for N-glycans because many of N-glycans whose expressions are significantly highly in stem cells were apparently originated from MEFs ( Fig. S11 and S13) .
After eliminating such glycans from the list (glycans shown in italic in Table S2 ), hierarchical clustering analysis based on the quantitative glycomic profiles of N-glycans, FOSs, GAGs, GSL glycans and O-glycans were performed. As shown in Fig. 4 , the hierarchical clustering analysis yielded a plausible classification scheme for human cells. hESCs and hiPSCs were clustered into a single clade, indicating the close similarity among the various human cell types analyzed in this study. Within this clade, hESC5, hiPS-2A and hiPS-12A, which were contaminated with substantial numbers of differentiating cells, were further subdivided into additional groups. NEC8 was located within the closest proximity to the stem cells, which appears to be reasonable considering that NEC8 cells have characteristics similar to EC cells, which are capable of pluripotent differentiation (28) . The carcinoma cells were clustered into a single clade, although their mutual correlations were generally low. Normal
cells (MRC5) as well as floating cells (HL60) fell into two distinct groups.
Regarding the classification of glycan side, SSEA-3, 4, 5 and Globo H (GSL-15, 17, 20 and 16, respectively), which are known to be pluripotent GSL glycan biomarkers, were clustered into a single clade among a total of ~200 glycans (Fig. 4a, a clade shown in red) . An additional four glycans (three O-glycans (O-7, 10 and 14) and one N-glycan (N-80)) were also clustered into this clade. Natunen et al recently reported that the specific binding of Tra-1-60 and Tra-1-81 occurs to glycans containing a tetrasaccharide structure, where type 1 lactosamine is β1,3-linked to type 2 lactosamine (29) . This group in fact detected Hex3HexNAc3, which proven to possess β1-3 -linked Gal at non-reducing end and was tentatively assigned to be core-2 branched O-glycan with Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAc sequences. In this study, we also confirmed the presence of β1-3 -linked Gal at nonreducing end of O-glycan having composition Hex3HexNAc3 (Fig.S12b-2 Glycans clustered into adjacent clades were also found to be highly stem cell-specific. In summary, (34) , suggesting that compensation by alternate glycogene(s) may occur. Total glycomics are anticipated to provide a straightforward measure to unveil the network of intra-and interglycomic correlations in such cases, under both normal and pathological conditions. This is the first report to delineate a comprehensive glycomic analysis of the major glycoconjugates of hESCs and hiPSCs. Recently, several pioneering studies have started to clarify the individual glycomes of hESCs and hiPSCs. For example, MS-based structurally intensive studies of the hESC N-glycome have been recently documented (35, 36) . Furthermore, Liang et al. reported the total GSL glycan profiles of two hESC lines (37) . However, there are no previous, structurally intensive glycomic studies regarding hESC GAGs or FOSs, to the best of the authors' knowledge. Moreover, the glycosylation of hiPSC-derived cellular components had not been studied prior to the current work, regardless of the type of glycoconjugate.
The N-glycomic profiles observed in this study mostly agree with previous observations. However, analysis of the total glycome of various human cells allowed a new in-depth comparison of their glycomic profiles. This comparison highlighted the unique glycosylation characteristics of each cell type and also identified a panel of novel pluripotency biomarkers. Recently, an unusual abundance of high-mannose glycans in hESCs was reported (36) . However, we observed that high-mannose type glycans were commonly the major components of not only stem cells but also carcinoma cells. We instead identified various structural feature of N-glycans (e.g., multiply fucosylated type, bisect and/or LacdiNAc type) that appeared to be associated with stemness. Glycomic analyses of hESC-derived GSL glycans were also consistent with previously reported observations (37) . However, since our analysis focused on glycan moieties following their release from lipids by EGCases, we eliminated the complexity associated with lipid heterogeneity. Furthermore, we substantially improved detection sensitivity by glycoblotting and subsequent aoWR (a MS-friendly tag) derivatization, thus enabling the detection of low-abundance GSL glycans.
It should be emphasized that absolute quantitation rather than relative quantitation allowed direct comparison of the expressed amounts of glycans originating from different types of glycoconjugates. As shown in Fig. 4 , glycans derived from various classes of glycoconjugates were successfully categorized into a single clade on the dendrogram, which assisted in the unveiling of inter-glycome correlations.
Indeed, well-known pluripotency biomarkers such as SSEA-3, 4 and 5 (GSL glycans), as well as the Tra-1-60 and Tra-1-81 epitopes (O-glycans), were clustered into a single clade. In other words, these glycans were identified as pluripotency biomarkers without any prior knowledge, demonstrating the power of the total glycomic approach for the discovery of cellular biomarkers.
That we could precisely identify known biomarkers by an omics-based approach also highlights the usefulness of the glycoconjugate-focused strategy, given that global proteomic studies often fail to identify known biomarkers because their expression levels are too low to be detected by MS (38) . This may suggest that glyco-biomarkers are more abundant than protein biomarkers because the same structural glycan can attach to several different proteins, thereby increasing the total concentration of the glycan and simplifying the detection of glyco-biomarkers vs. protein biomarkers. However, it is also possible that glycoproteins with a specific glycosylation profile (both in terms of structure and glycan attachment site) would provide a more specific biomarker than glycans alone. Now that panels of stem cell-specific N-and O-glycans, as well as GAG candidates, have been identified, our next focus will be directed toward the identification of proteins that carry such marker glycans. This is true also for GSL glycans. A given combination of glycan and lipid moieties may also allow for the identification of even more specific and functional biomarkers. The validity of the identified pluripotency biomarker candidates should also be validated by other means including flow cytometry experiments.
The advantage of the total cellular glycome rather than individual glycomes for the description/characterization of cells is evident when the correlation matrix created by quantitative total glycomics is compared with those created by analysis of the N-glycome, O-glycome, glycosaminoglycome, GSL glycan glycome, and FOS glycome (Fig. S7) . Although each individual glycome could discriminate stem cells from other cells to a certain extent, the discrimination power was most efficient when quantitative information regarding the glycome in its entirety was taken into account. Structures of glycans of all classes specifically observed in hESCs and hiPSCs tended to be immature in general, suggesting the presence of stem cell-specific glycosylation spectra. The current analysis revealed the high similarity of the total cellular glycome between hESCs and hiPSCs, although it was suggested that hESCs are more homogeneous than hiPSCs from a glycomic standpoint.
In conclusion, this study set forth a concept of total cellular glycomics (including the analysis of Nand O-linked glycans derived from glycoproteins, GSL glycans, GAGs, and FOSs) to describe/characterize cells and established techniques to enable it. By using the techniques described herein, the glycomes of various human stem and non-stem cells were clarified for the first time. Cellular glycomes were found to be highly cell type-specific and capable of functioning as unique cellular descriptors as demonstrated by the identification of known pluripotency biomarkers as well as novel candidates. We anticipate that total cellular glycomics will facilitate the description of numerous cell types, as well as the discrimination between normal and pathological conditions. A panoramic view of the total glycome also allows the investigator to decipher intra-and inter-glycomic correlations, thus opening a new avenue in systems biology glycomics. Extraction of GSLs and GAGs. The streamlined GAG and GSL extraction procedures were essentially the same as previously described (12, 16) . Detailed procedures and materials are provided in SI Materials and Methods.
Glycoblotting. N-glycans, FOSs and GSL glycans were subjected to glycoblotting as previously described (13) Statistical analysis. Cluster analyses were performed with software Cluster 3.0. The calculated dendrogram and correlation matrix were visualized by using TreeView 1.6 software. Pearson productmoment correlation coefficient r between all cells was calculated based on the absolute amounts of all detected glycans (amount/100 µg of protein). Correlation matrices were produced by aligning r with the cells by using Microsoft Excel. Box-and whisker plots were generated using TIBCO Spotfire software (TIBCO Software Inc., Göteborg, Sweden). The absolute amount of each glycan (pmol/100 μg protein) was analyzed by using Cluster 3.0 software.
FIGURE LEGENDS
The heat map with clustering was acquired by using Java Treeview software. The region shown in red indicates a clade where SSEA-3, 4, 5 and the Tra-1-60 and Tra-1-81 epitopes are clustered. Glycans are marked with blue based on the p-value when the expressed amount was compared between stem cells (hESCs and hiPSCs) and non-stem cells.
